{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T05:17:29Z","timestamp":1777785449240,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Am Psychiatr Nurses Assoc"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Cannabis use for medical condition has significantly increased over the past 20 years with 33 states and the District of Columbia passing laws legalizing medical cannabis. Five qualifying psychiatric disorders have been identified. The objective of this review article is to present a brief history of medical cannabis, the evidence for the qualifying psychiatric conditions, and to discuss the implications for psychiatric nurses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>A review of the literature on the five qualifying psychiatric disorders was conducted. Databases searched included CINAHL, PubMed, Cochrane Library, MedLine Plus, and EMBASE. Keywords were cannabis, medical cannabis, delta-9-tetrahydrocannabinaol, cannabidiol, and psychiatric disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The evidence that medical cannabis or cannabinoids is an effective treatment for the qualifying psychiatric disorders (e.g., posttraumatic stress disorder, agitation in Alzheimer\u2019s disease and other dementias, Tourette\u2019s syndrome, anxiety, and obsessive-compulsive disorder) is too weak and of low quality to recommend as an intervention at this time. A discussion of the implications of these findings for psychiatric nurses is offered based on the published guidelines by the American Nurses Association and National Council of State Boards of Nursing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is a significant gap between evidence supporting the effectiveness of medical cannabis for psychiatric disorders and patient interest and use of cannabis for such conditions as well as other psychiatric symptoms. There are tremendous opportunities for psychiatric nurses to make an impact both clinically and be conducting research in this emerging field. We need to educate ourselves and our patients about the benefits and risks of medical cannabis and to help patients make informed decisions about their health care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1078390320945791","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T07:42:11Z","timestamp":1596872531000},"page":"91-103","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Medical Cannabis and Psychiatric Disorders: Implications for Psychiatric Nurses"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-7389","authenticated-orcid":false,"given":"Carla J.","family":"Groh","sequence":"first","affiliation":[{"name":"Carla J. Groh, PhD, PMHNP-BC, FAAN, University of Detroit Mercy, Detroit, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"key":"bibr1-1078390320945791","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0016"},{"key":"bibr2-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3889-y"},{"key":"bibr3-1078390320945791","unstructured":"American Academy of Pediatrics. (2018). AAP raises concerns about increasing marijuana use during pregnancy and breastfeeding. https:\/\/healthychildren.org\/English\/news\/Pages\/AAP-concerned-about-marijuana-use-during-pregnancy-and-breastfeeding.aspx"},{"key":"bibr4-1078390320945791","unstructured":"American College of Obstetricians and Gynecologists. (2017). Marijuana use during pregnancy and lactation. https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/10\/marijuana-use-during-pregnancy-and-lactation"},{"key":"bibr5-1078390320945791","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr6-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2019.21"},{"key":"bibr7-1078390320945791","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8071058"},{"key":"bibr8-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.6"},{"key":"bibr9-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2374"},{"key":"bibr10-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4885-9"},{"key":"bibr11-1078390320945791","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr12-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000180"},{"key":"bibr13-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2018.0437"},{"key":"bibr14-1078390320945791","unstructured":"Food and Drug Administration. (2019). What we should know about using cannabis, including CBD, when pregnant and breastfeeding. https:\/\/www.fda.gov\/consumers\/consumer-updates\/what-you-should-know-about-using-cannabis-including-cbd-when-pregnant-or-breastfeeding"},{"key":"bibr15-1078390320945791","doi-asserted-by":"crossref","unstructured":"Fraser G. A. (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neuroscience & Therapeutics, 15(1), 84-88. https:\/\/doi.org\/10.1111\/j.1755-5949.2008.00071x","DOI":"10.1111\/j.1755-5949.2008.00071.x"},{"key":"bibr16-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.4500"},{"key":"bibr17-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2347-8"},{"key":"bibr18-1078390320945791","doi-asserted-by":"crossref","unstructured":"Gunn J. K. L., Rosales C. B., Center K. E., Nunez A., Gibson S. J., Christ C., Ehin J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: A systemic review and meta-analysis. BMJ Open, 6, e009986. https:\/\/doi.org\/10.1136\/bmjopem-2015-009986","DOI":"10.1136\/bmjopen-2015-009986"},{"key":"bibr19-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.7517"},{"key":"bibr20-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1111\/add.13670"},{"key":"bibr21-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.003"},{"key":"bibr22-1078390320945791","volume-title":"Oral presentation at the Psychopharmacology Update","author":"Hill K. P.","year":"2019"},{"key":"bibr23-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.11.002"},{"key":"bibr24-1078390320945791","unstructured":"Kayser R. R. (2020). Effects of Marijuana on Symptoms of OCD (ECOS). National Library of Medicine, ClinicalTrial.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03274440"},{"key":"bibr25-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-136"},{"key":"bibr26-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1111\/add.14459"},{"key":"bibr27-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17030325"},{"key":"bibr28-1078390320945791","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01365"},{"key":"bibr29-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18020202"},{"key":"bibr30-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1998.tb10127.x"},{"key":"bibr31-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-25028"},{"key":"bibr32-1078390320945791","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0417"},{"key":"bibr33-1078390320945791","volume-title":"The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for research","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"bibr34-1078390320945791","unstructured":"National Association of Nurse Practitioners in Women\u2019s Health. (2020). Marijuana use during pregnancy and lactation (Position statement). https:\/\/www.npwh.org\/lms\/filebrowser\/file?fileName=MJ%20Use%20during%20pg%20and%20lactation%20Final.pdf"},{"key":"bibr35-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1016\/S2155-8256(18)30082-6"},{"key":"bibr36-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.s1-5.123.363"},{"key":"bibr37-1078390320945791","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20190919-02"},{"key":"bibr38-1078390320945791","unstructured":"Peprah K., McCormack S. (2019). Medical cannabis for the treatment of dementia: A review of clinical effectiveness and guidelines. Canadian Agency for Drugs and Technologies in Health. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546328\/"},{"key":"bibr39-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0212-3"},{"key":"bibr40-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-020-0880-9"},{"key":"bibr41-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706112"},{"key":"bibr42-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-1889"},{"key":"bibr43-1078390320945791","doi-asserted-by":"crossref","unstructured":"Sarris J., Sinclairm J., Karamacoska D., Davidson M., Firth J. (2020). Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry, 20, 24. http:\/\/doi.org\/10.1186\/s12888-2409-8","DOI":"10.1186\/s12888-019-2409-8"},{"key":"bibr44-1078390320945791","unstructured":"Schlosser E. (1994, August). Reefer madness. The Atlantic. https:\/\/www.theatlantic.com\/magazine\/archive\/1994\/08\/reefer-madness\/303476\/"},{"key":"bibr45-1078390320945791","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18-041"},{"key":"bibr46-1078390320945791","unstructured":"Substance Abuse and Mental Health Services Administration. (2018). NSDUH detailed tables. https:\/\/www.samhsa.gov\/data\/report\/2017-nsduh-annual-national-report"},{"key":"bibr47-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1177\/0009922819875550"},{"issue":"11","key":"bibr48-1078390320945791","first-page":"6","volume":"14","author":"Theisen E.","year":"2019","journal-title":"American Nurse Today"},{"key":"bibr49-1078390320945791","doi-asserted-by":"crossref","unstructured":"Volicer L., Stelly M., Morris J., McLaughlin J., Volicer B. J. (1997). Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease. International Journal of Geriatric Psychiatry, 12(9), 913-919. https:\/\/doi.org\/10.1002\/(SICI)1099-1166(199709)12:9<913:AID-GPS663>3.0.CO;2-D","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D"},{"key":"bibr50-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0343-1"},{"key":"bibr51-1078390320945791","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"bibr52-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358"},{"key":"bibr53-1078390320945791","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15r10036"},{"key":"bibr54-1078390320945791","unstructured":"Woodward B. (2017). Marijuana and the psychiatric patient. Psychiatric Times, 34(4). https:\/\/www.psychiatrictimes.com\/couch-crisis\/marijuana-and-psychiatric-patient"},{"key":"bibr55-1078390320945791","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2012.11.022"}],"container-title":["Journal of the American Psychiatric Nurses Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078390320945791","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078390320945791","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078390320945791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:44:00Z","timestamp":1777491840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078390320945791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1177\/1078390320945791"],"URL":"https:\/\/doi.org\/10.1177\/1078390320945791","relation":{},"ISSN":["1078-3903","1532-5725"],"issn-type":[{"value":"1078-3903","type":"print"},{"value":"1532-5725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]}}}